Genitourinary Pathology

<p>Part I:  Update on Prostate Tumor Pathology</p><p> </p><p>1: Anatomy of the Prostate Revisited: Implications for Prostate Biopsy and Zonal Origins of Prostate Cancer</p><p>Samson W. Fine and Rohit Mehra</p><p> </p><p>2: Contemporary Gleason Grading System </p><p>Kiril Trpkov</p><p> </p><p>3: Contemporary Prostate Cancer Staging</p><p>Christopher G. Przybycin, Sara M. Falzarano, and Cristina Magi-Galluzzi</p><p> </p><p>4: Prostate Cancer Reporting on Biopsy and Radical Prostatectomy Specimens </p><p>Samson W. Fine</p><p> </p><p> </p><p>5: Unusual Epithelial and Non-Epithelial Neoplasms of the Prostate</p><p>Adeboye O. Osunkoya and Cristina Magi-Galluzzi</p><p> </p><p>6: Management Implications Associated with Unusual Morphologic Entities of the Prostate</p><p>Viraj A. Master, Jonathan Huang, Cristina Magi-Galluzzi, and Adeboye O. Osunkoya</p><p> </p><p>7: Nomograms for Prostate Cancer Decision-Making</p><p>Cesar E. Ercole, Michael W. Kattan, and Andrew J. Stephenson</p><p> </p><p>8: Genetic Determinants of Familial and Hereditary Prostate Cancer</p><p>Jesse K. McKenney,  Christopher G. Przybycin, and Cristina Magi-Galluzzi</p><p> </p><p>9: New Molecular Markers of Diagnosis and Prognosis  in Prostate Cancer </p><p>Rajal B. Shah and Ritu Bhalla</p><p> </p><p>10: Intraoperative Consultation for Prostate Tumors: Challenges</p> and Implications for Treatment<p></p><p>Hiroshi Miyamoto and Steven S. Shen</p><p> </p><p>11: Genomics and Epigenomics of Prostate Cancer</p><p>Juan Miguel Mosquera, Pei-Chun Lin, and Mark A. Rubin </p><p> </p><p> </p><p> </p><p>Part II: Update on Bladder Tumor Pathology</p><p> </p><p> </p><p>12: Anatomy of the Urinary Bladder Revisited:  Implications for Diagnosis and Staging </p><p>of  Bladder Cancer</p><p>Victor E. Reuter</p><p> </p><p>13:  Classification and Histologic Grading of Urothelial Neoplasms by the WHO 2004 (ISUP 1998) Criteria</p><p>Jesse K. McKenney</p><p> </p><p>14:  Reporting of Bladder Cancer in TURBT and Cystectomy Specimens</p><p>Jesse K. McKenney</p><p> </p><p>15: Urothelial Carcinoma Variants:  Morphology and Association with Outcomes</p><p>Gladell P. Paner  and Donna E. Hansel</p><p> </p><p>16: Independent Predictors of Clinical Outcomes and Prediction Models on Bladder and Upper Urinary Tract Cancer</p><p>Maria Carmen Mir, Andrew J. Stephenson, and Michael W. Kattan</p><p> </p><p>17: Familial Urothelial Carcinomas</p><p>Christopher G. Przybycin and Jesse K. McKenney</p><p> </p><p>18: New Molecular Markers with Diagnostic and Prognostic Values in Bladder Cancer</p><p>Hikmat A. Al-Ahmadie and Gopa Iyer</p><p> </p><p>19: Intraoperative Consultation for Bladder Tumors: Challenges</p> and Implications for Treatment<p></p><p>Hiroshi Miyamoto and Steven S. Shen</p><p> </p><p>20: Genetic and Epigenetic Alterations in Urothelial Carcinoma</p><p>Hikmat A. Al-Ahmadie and Gopa Iyer</p><p> </p><p>21: Urine Cytology</p><p>Jordan P. Reynolds</p><p> </p><p>Part III:  Update on Renal Tumor Pathology</p><p> </p><p>22: Anatomy of the Kidney Revisited: Implications for Diagnosis and Staging of Renal Cell Carcinoma</p><p>Stephen M. Bonsib</p><p> </p><p>23: Classification of Adult Renal Tumors and Grading of Renal Cell Carcinoma</p><p>William R. Sukov and John C. Cheville</p><p> </p><p> </p><p>24:  Tumor Staging for Renal Pathology</p><p>Stephen M. Bonsib</p><p> </p><p>25:  Surgical Pathology Reporting of Renal Cell Carcinomas </p><p>Christopher G. Przybycin, Angela Wu, and Lakshmi P. Kunju</p><p> </p><p>26: Newly Described Entities in Renal Tumor Pathology</p><p>Angela Wu, Christopher G. Przybycin, and Lakshmi P. Kunju</p><p> </p><p>27: Clinical and Management Implications Associated with Histologic Subtypes of Renal Cell Carcinomas</p><p>Maria Carmen Mir, Brian I. Rini, and Steven C. Campbell</p><p> </p><p>28: Independent Predictors of Clinical Outcomes and Prediction Models for Renal Tumor Pathology</p><p>Nils Kroeger, Daniel Y.C. Heng, and Michael W. Kattan</p> 29:  Pathology of Inherited Forms of Renal CarcinomaMaria J. Merino<p> </p><p>30: The Utility of Immunohistochemistry in the Differential Diagnosis of Renal Cell Carcinomas</p><p>Ming Zhou and Fang-Ming Deng</p><p> </p><p>31: Intraoperative Consultation for Renal Masses: Challenges and Implications for Treatment</p><p>Hiroshi Miyamoto and Steven S. Shen</p><p> </p><p>32: Genetic and Epigenetic Alterations in Renal Cell Carcinoma</p><p>Fang-Ming Deng and Ming Zhou</p><p> </p><p>33: Role of Needle Biopsy in Renal Masses: Past, Present, Future</p><p>Ying-Bei Chen</p><p> </p><p> </p><p>Part IV: Update on Testicular Tumor Pathology</p><p> </p><p> </p><p> </p><p>34: Anatomy of the Testis and Staging of its Cancers: Implications for Diagnosis</p><p> </p><p>Daniel M. Berneyand Thomas M. Ulbright</p><p> </p><p> </p><p> </p><p>35: Classification of Testicular Tumors </p><p> </p><p>Cristina Magi-Galluzzi and Thomas M. Ulbright</p><p></p><p></p><p>36: Testicular Cancer Reporting on Radical Orchiectomy and Retroperitoneal Lymph Node Dissection After Treatment</p><p>Daniel M. Berney</p><p> </p><p>37: Difficult or Newly Described Morphologic Entities in Testicular Neoplasia</p><p>Daniel M. Berney and Thomas M. Ulbright</p><p> </p><p>38: Clinical Implications of the Different Histologic Subtypes of Testicular Tumors</p><p>Timothy G</p>illigan<p></p><p> </p><p>39: Familial Syndromes Associated with Testicular Tumors</p><p>Jesse K. McKenney, Claudio Lizarralde, and Cristina Magi-Galluzzi</p><p> </p><p>40: Molecular and Immunohistochemical Markers of Diagnostic and Prognostic Value in Testicular Tumors </p><p>Victor E. Reuter</p><p> </p><p>41: Intraoperative Consultation for Testicular Tumors: Challenges and Implications for Treatment</p><p>Hiroshi Miyamoto and Steven S. Shen</p><p> </p><p>42: Genetic and Epigenetic Alterations in Testicular Tumors</p><p>Pallavi A. Patil and Cristina Magi-Galluzzi</p><p></p>